Browse by Audience
MEMBER

Update Your Profile
Member Spotlights
Refer a Member: IASP Champions
Join a Special Interest Group (SIG)
Find a Chapter
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Papers of the Week
Webinars and Podcasts
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Webinars & Podcasts
Curricula
Graduate Opportunities
Events

PATIENT & CAREGIVER

RELIEF News
Resources for Living with Pain
Global Alliance of Partners in Pain Advocacy (GAPPA)
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner

gy2022-1-3
I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Is there a rational basis for cannabinoids research and development in ocular pain therapy? A systematic review of preclinical evidence.

< BACK TO ARCHIVE


2021 Dec 06


Biomed Pharmacother


http://www.ncbi.nlm.nih.gov/pubmed/34891121?dopt=Abstract


146

Is there a rational basis for cannabinoids research and development in ocular pain therapy? A systematic review of preclinical evidence.

Authors

Is there a rational basis for cannabinoids research and development in ocular pain therapy? A systematic review of preclinical evidence.
Scuteri D, Rombolà L, Hamamura K, Sakurada T, Watanabe C, Sakurada S, Guida F, Boccella S, Maione S, Gallo Afflitto G, Nucci C, Tonin P, Bagetta G, Corasaniti MT
Biomed Pharmacother. 2021 Dec 06; 146:112505.
PMID: 34891121.

Abstract

Purpose of the present systematic review is to investigate preclinical evidence in favor of the working hypothesis of efficacy of cannabinoids in ocular pain treatment.
Read This Paper